people get EXEL breaking news and analysis by email alert.
Get email alerts on EXEL
To screen ETFs by asset class, performance, yield and more, check out the
Exelixis, Inc. (EXEL)
Be faster and smarter about EXEL. Get PRO Alerts on all your stocks for just $30.
Want to be faster and smarter about EXEL? Upgrade to PRO Alerts.
vs. ETF Alternatives
Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog
at Zacks.com (Dec 17, 2014)
Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
at Zacks.com (Dec 16, 2014)
Best biotech trades on ASH meeting: Kensho
at CNBC.com (Dec 8, 2014)
Exelixis Shares Down on COMET-2 Study Results on Cabozantinib - Analyst Blog
at Zacks.com (Dec 2, 2014)
Will Exelixis (EXEL) Disappoint This Earnings Season? - Analyst Blog
at Zacks.com (Nov 3, 2014)
See More »
Other News & PR
See More »
Xignite quote data
© 2015 Seeking Alpha